Where does Vivex Biologies Group, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Vivex Biologies Group, Inc. ranks #38,251 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Vivex Biologies Group, Inc. hold?

Vivex Biologies Group, Inc. holds 7 US utility patents granted between 2021 and 2023, spanning 7 technology areas.

What is Vivex Biologies Group, Inc.'s Innovation Score?

Vivex Biologies Group, Inc. has an Innovation Score of 42.7 out of 100 (top 30% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Vivex Biologies Group, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Vivex Biologies Group, Inc..

What does claim depth mean for Vivex Biologies Group, Inc.'s patents?

Vivex Biologies Group, Inc.'s patents average 15.9 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Vivex Biologies Group, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Vivex Biologies Group, Inc.

Q: What technology areas does Vivex Biologies Group, Inc. focus on?

Vivex Biologies Group, Inc.'s top technology area is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles) with 7 patents, ranking #439 of 2,589 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

USPTO PatentsView assignee record - 7 granted patents across 7 technology areas, recorded in grant years 2021–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Vivex ranks #38,251 of 49,997 tracked US assignees by granted-patent volume, with 7 patents across 7 technology areas.

#38,251
of 49,997 US assignees by volume: Top 30%
by Innovation Score (42.7/100): 15.9
avg claims per patent

USPTO PatentsView assignee plate

Corpus R38251 · US Corporation #38,251 · 7 grants

GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 7 grants
LOWER-Q #38,251/49,997
PHOTO-FINISH Visitlock
CPC-NARROW A61L · 7 areas
INNOV-PAR 42.7/100
CLAIMS-RICH 15.9 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2021–2023 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Visitlock LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Vivex’s 42.7 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 7.2 pts (17%) Velocity 16.7 pts (39%) Breadth 9.4 pts (22%) Claim depth 9.5 pts (22%)

Qualcomm Incorporated · highest

85
Vivex Biologies Group · this assignee

43
3D Lighting… · lowest

7

What this shows Vivex's Innovation Score is 42.7/100 (top 30% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Vivex?

Each dot is one of Vivex’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Vivex’s own 15.9 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Vivex vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Vivex's grants concentrate

Vivex Biologies Group, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 100% of grants classified under A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;). Peak complete grant year is 2023 (4 grants) versus a trough of 1 in 2022. By volume, Vivex sits between Visitlock LLC and Volansi, Inc..

Vivex's three-year grant acceleration

Vivex Biologies Group, Inc. shows 5 grants in 2022–2024 against only 2 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Visitlock

7
Viskase Companies

7
Visualcamp

7
Vitalix

7
Viza Pte

7
Vmock

7
Vokee Applications

7
Volansi

7
Vivex Biologies G… ◀

7

What this shows Vivex holds 7 patents at rank #38,228, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Vivex

By rank, the assignees closest to #38,228 in granted patent volume.

Leaders in A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects…)

Other assignees with the most granted patents in Vivex's primary technology class.

Vivex's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

43 Top 30% higher than 70% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2021–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2021–2019 baseline. Full figures in the table below.

View data table

Vivex Biologies Group, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2021	2	28.6%
2022	1	14.3%
2023	4	57.1%

Which technologies does Vivex Biologies Group, Inc. patent most?

A61L - Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES; Materials FOR Bandages, Dressings, Absorbent Pads OR Surgical Articles 7

A01N - Preservation OF Bodies OF Humans OR Animals OR Plants OR Parts Thereof ; Biocides, e.g. AS Disinfectants, AS Pesticides OR AS Herbicides ; Pest Repellants OR ATTRACTANTS; Plant Growth Regulators 4

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

C08L - Compositions OF Macromolecular Compounds 1

A61B - DIAGNOSIS; SURGERY; Identification 1

A61F - Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive DEVICES; FOMENTATION; Treatment OR Protection OF Eyes OR EARS; Bandages, Dressings OR Absorbent PADS; Firs 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Vivex Biologies Group, Inc.'s patent record in context - here's where to go next.

Vivex Biologies Group, Inc.'s lead technology class is A61L (Methods OR Apparatus FOR Sterilising Materials OR Objects IN GENERAL; Disinfection, Sterilisation OR Deodorisation OF AIR; Chemical Aspects OF Bandages, Dressings, Absorbent Pads OR Surgical ARTICLES;), 100% of its portfolio - see every assignee active in that class. Explore A61L
Ranked #38,251 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Vivex Biologies Group, Inc. against Visitlock LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 42.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.